scholarly article | Q13442814 |
P50 | author | Cezmi Akdis | Q86752470 |
Mubeccel Akdis | Q89605992 | ||
Cevdet Ozdemir | Q90799607 | ||
Umut Can Kucuksezer | Q91712505 | ||
P2860 | cites work | Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro | Q37360604 |
Role of interleukin 10 in specific immunotherapy | Q37387064 | ||
T regulatory cells and their counterparts: masters of immune regulation | Q37473347 | ||
Therapeutic manipulation of immune tolerance in allergic disease | Q37567423 | ||
Dendritic cells: bridging innate and adaptive immunity in atopic dermatitis | Q37683115 | ||
Immunological mechanisms of allergen-specific immunotherapy | Q37861875 | ||
Mechanisms of subcutaneous allergen immunotherapy | Q37870449 | ||
Mechanisms of immunotherapy to wasp and bee venom | Q37897667 | ||
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs | Q38049856 | ||
Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report | Q38090066 | ||
Epicutaneous allergen-specific immunotherapy ameliorates grass pollen-induced rhinoconjunctivitis: A double-blind, placebo-controlled dose escalation study | Q40309560 | ||
Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens | Q42261747 | ||
Histamine upregulates Th1 and downregulates Th2 responses due to different patterns of surface histamine 1 and 2 receptor expression | Q43578508 | ||
Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis | Q43959432 | ||
IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy | Q44429951 | ||
Suppression of B-cell activation and IgE, IgA, IgG1 and IgG4 production by mammalian telomeric oligonucleotides | Q44795516 | ||
IL-10 suppresses CD2-mediated T cell activation via SHP-1. | Q46295443 | ||
A double-blind, placebo-controlled birch allergy vaccination study: inhibition of CD23-mediated serum-immunoglobulin E-facilitated allergen presentation | Q47988492 | ||
Bacillus Calmette-Guérin-induced interleukin-12 did not additionally improve clinical and immunologic parameters in asthmatic children treated with sublingual immunotherapy | Q47988526 | ||
Interleukin-10 and the interleukin-10 receptor | Q24290912 | ||
Tracking antigen-specific T-cells during clinical tolerance induction in humans | Q24320083 | ||
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 | Q24672849 | ||
Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation | Q24676080 | ||
Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases | Q28131652 | ||
Immunological mechanisms of allergen-specific immunotherapy | Q28265326 | ||
Regulation of immune responses by TGF-beta | Q28271433 | ||
Mechanisms of peripheral tolerance to allergens | Q29027397 | ||
Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes | Q29619621 | ||
Allergens and their role in the allergic immune response | Q30453700 | ||
Specific immunotherapy and turning off the T cell: how does it work? | Q30485173 | ||
Long-term clinical efficacy of grass-pollen immunotherapy | Q33870492 | ||
Regulation of specific immune responses by chemical and structural modifications of allergens | Q33928064 | ||
Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology | Q34165569 | ||
Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. | Q34168692 | ||
Prevention of arthritis by interleukin 10-producing B cells | Q34178104 | ||
IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses | Q34330562 | ||
Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells | Q34548321 | ||
Grass pollen immunotherapy induces Foxp3-expressing CD4+ CD25+ cells in the nasal mucosa | Q34590830 | ||
Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll-like receptors | Q34598797 | ||
Genes of tolerance | Q35855013 | ||
Histamine in allergic inflammation and immune modulation | Q36098788 | ||
Generation, migration and function of circulating dendritic cells | Q36507785 | ||
Healthy immune response to allergens: T regulatory cells and more | Q36615443 | ||
In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure | Q36979997 | ||
Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper | Q37202883 | ||
Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. | Q37256978 | ||
Natural course of sensitization to food and inhalant allergens during the first 6 years of life. | Q50648208 | ||
Design, engineering and in vitro evaluation of MHC class-II targeting allergy vaccines. | Q51065763 | ||
A major allergen gene-fusion protein for potential usage in allergen-specific immunotherapy. | Q51543765 | ||
Human NK1 and NK2 subsets determined by purification of IFN-gamma-secreting and IFN-gamma-nonsecreting NK cells. | Q51725629 | ||
IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain—containing protein tyrosine phosphatase 1 | Q57265326 | ||
Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections | Q57266970 | ||
Immune regulation by CD4+CD25+T cells and interleukin-10 in birch pollen-allergic patients and non-allergic controls | Q57266988 | ||
Cutting Edge: TGF- Signaling Is Required for the In Vivo Expansion and Immunosuppressive Capacity of Regulatory CD4+CD25+ T Cells | Q58131166 | ||
Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies | Q60312277 | ||
Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen | Q74286698 | ||
Interleukin-10 inhibits expression of both interferon alpha- and interferon gamma- induced genes by suppressing tyrosine phosphorylation of STAT1 | Q74462942 | ||
Determinants and mechanisms of human immune responses to bee venom phospholipase A2 | Q77344184 | ||
Allergy and hypersensitivity: mechanisms of allergic disease | Q79213790 | ||
Mechanisms of allergen-specific immunotherapy | Q79828953 | ||
Regulatory NK cells suppress antigen-specific T cell responses | Q80455086 | ||
Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation | Q80754264 | ||
Regulation of T cells and cytokines by the interleukin-10 (IL-10)-family cytokines IL-19, IL-20, IL-22, IL-24 and IL-26 | Q82028854 | ||
Induction and maintenance of allergen-specific FOXP3+ Treg cells in human tonsils as potential first-line organs of oral tolerance | Q82334324 | ||
Mechanisms of allergen-specific immunotherapy | Q83143842 | ||
The many routes of dendritic cells to ensure immune regulation | Q84003721 | ||
Grass transcutaneous immunotherapy in children with seasonal rhinoconjunctivitis | Q84632194 | ||
Triggering of specific Toll-like receptors and proinflammatory cytokines breaks allergen-specific T-cell tolerance in human tonsils and peripheral blood | Q85782136 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 12 | |
P304 | page(s) | 505-513 | |
P577 | publication date | 2013-12-20 | |
P1433 | published in | Korean journal of pediatrics | Q26853872 |
P1476 | title | Mechanisms of immune tolerance to allergens in children | |
P478 | volume | 56 |
Q87232429 | Atopy in children with the enthesitis-related arthritis (ERA) subtype of juvenile idiopathic arthritis is associated with a worse outcome |
Q38203380 | Immunotherapy in allergy and cellular tests: state of art. |
Q39576051 | Increase of Frequency and Modulation of Phenotype of Regulatory T Cells by Atorvastatin Is Associated with Decreased Lung Inflammatory Cell Infiltration in a Murine Model of Acute Allergic Asthma |
Q92744564 | Newly identified T cell subsets in mechanistic studies of food immunotherapy |
Search more.